Xianglin Yuan

22PUBLICATIONS
70CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 19, 2026
HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence.

|May 13, 2026
Correction: ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I.

|Jan 28, 2026
The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress.

Duo Xu, Qian Wang, Meng Lyu

|Nov 19, 2025
Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis.

Chunya Li, Aifeina Aili, Qingqing Yu

|Nov 03, 2025
Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy.

Xinyi Chen, Mu Yang, Yongbiao Huang

|Apr 17, 2025
Unveiling FAM111B: A Pan-Cancer Biomarker for DNA Repair and Immune Infiltration.

Fang Wei, Wanying Li, Ting Zhou

Pageof 4

Frequent Collaborators

9 joint publications

Bo Liu

6 joint publications

Yuan Wang

4 joint publications

Yuanhui Liu

4 joint publications

Xinyi Chen